πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 102 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 9416361

Splice-region antisense composition and method

Sarepta Therapeutics, Inc. Β· Granted Tue Aug 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9394323

Antisense antiviral compound and method for treating influenza viral infection

Sarepta Therapeutics, Inc. Β· Granted Tue Jul 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9382536

Antisense antiviral compounds and methods for treating a filovirus infection

Sarepta Therapeutics, Inc. Β· Granted Tue Jul 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 30 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9347063

Oligonucleotide analog and method for treating flavivirus infections

Sarepta Therapeutics, Inc. Β· Granted Tue May 24 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 19 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9278987

Functionally-modified oligonucleotides and subunits thereof

Sarepta Therapeutics, Inc. Β· Granted Tue Mar 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9249243

Antibacterial antisense oligonucleotide and method

Sarepta Therapeutics, Inc. Β· Granted Tue Feb 02 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9238042

Antisense modulation of interleukins 17 and 23 signaling

Sarepta Therapeutics, Inc. Β· Granted Tue Jan 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9234198

Multiple exon skipping compositions for DMD

Sarepta Therapeutics, Inc. Β· Granted Tue Jan 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9217148

Exon skipping compositions for treating muscular dystrophy

Sarepta Therapeutics, Inc. Β· Granted Tue Dec 22 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9161948

Peptide oligonucleotide conjugates

Sarepta Therapeutics, Inc. Β· Granted Tue Oct 20 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 15 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9068185

Antisense modulation of nuclear hormone receptors

Sarepta Therapeutics, Inc. Β· Granted Tue Jun 30 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 25 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9066967

Oligonucleotide analogues targeting human LMNA

Sarepta Therapeutics, Inc. Β· Granted Tue Jun 30 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 25 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8933216

Immunosuppression compound and treatment method

Sarepta Therapeutics, Inc. Β· Granted Tue Jan 13 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8906872

Antisense antiviral compound and method for treating ssRNA viral infection

Sarepta Therapeutics, Inc. Β· Granted Tue Dec 09 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8895722

Splice-region antisense composition and method

Sarepta Therapeutics, Inc. Β· Granted Tue Nov 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8877725

Peptide conjugated, inosine-substituted antisense oligomer compound and method

Sarepta Therapeutics, Inc. Β· Granted Tue Nov 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8871918

Multiple exon skipping compositions for DMD

Sarepta Therapeutics, Inc. Β· Granted Tue Oct 28 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8865883

Multiple exon skipping compositions for DMD

Sarepta Therapeutics, Inc. Β· Granted Tue Oct 21 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8835402

Compound and method for treating myotonic dystrophy

Sarepta Therapeutics, Inc. Β· Granted Tue Sep 16 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8785410

Antisense composition and method for treating muscle atrophy

Sarepta Therapeutics, Inc. Β· Granted Tue Jul 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8785407

Antisense antiviral agent and method for treating ssRNA viral infection

Sarepta Therapeutics, Inc. Β· Granted Tue Jul 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8779128

Oligonucleotide analogues having modified intersubunit linkages and/or terminal groups

Sarepta Therapeutics, Inc. Β· Granted Tue Jul 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8741863

Compound and method for treating myotonic dystrophy

Sarepta Therapeutics, Inc. Β· Granted Tue Jun 03 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 29 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8703735

Antisense antiviral compounds and methods for treating a filovirus infection

Sarepta Therapeutics, Inc. Β· Granted Tue Apr 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted